Literature DB >> 150

Mercury inhibition of avian fatty acid synthetase complex.

W E Donaldson.   

Abstract

(1) Subcutaneous or intra-abdominal injections of 8 mg of HgCl2/100 g body weight markedly depressed hepatic fatty acid synthetase activity of chicks at 1 h post-injection. The depression occurred despite the fact that the chicks continued to eat up until the time they were killed. Under these same conditions, the hepatic activity of acetyl-CoA carboxylase (EC 6.4.1.2) was not affected by HgCl2, while the activity of the mitochondrial system of fatty acid elongation was stimulated. (2) When 2-mercaptoethanol was included in the incubation medium for a highly purified preparation of fatty acid synthetase, 500 muM HgCl2 was required to show definite inhibition of the enzyme. When 2-mercaptoethanol was omitted, 50 muM HgCl2 was inhibitory and 100 muM HgCl2 abolished enzyme activity. (3) 2 mM dithiothreitol completely protected the purified fatty acid synthetase preparation from inhibition by 100 muM HgCl2. When dithiothreitol was added after the addition of enzyme to the mercury-containing medium, protection of the enzyme was not complete. (4) Dialysis of cytosol fractions from chicks injected with HgCl2 against 500 vol. of 0.2 M potassium phosphate buffer (pH 7.0) containing 1 mM EDTA and 10 mM dithiothreitol for 4 h at 4 degrees stimulated the fatty acid synthetase activity of the fractions. Dialysis of cytosol fractions from noninjected chicks under the same conditions was without effect on fatty acid synthetase activity. (5) These data support the hypothesis that the inhibitory effect of HgCl2 administered in vivo on hepatic fatty acid synthetase activity in chicks is mediated through the interaction of mercury with the sulfhydryl groups of the enzyme.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 150     DOI: 10.1016/0009-2797(75)90003-4

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  28 in total

1.  Non-invasive ventilation in acute respiratory failure.

Authors: 
Journal:  Thorax       Date:  2002-03       Impact factor: 9.139

2.  Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial.

Authors:  P K Plant; J L Owen; M W Elliott
Journal:  Lancet       Date:  2000-06-03       Impact factor: 79.321

3.  One year period prevalence study of respiratory acidosis in acute exacerbations of COPD: implications for the provision of non-invasive ventilation and oxygen administration.

Authors:  P K Plant; J L Owen; M W Elliott
Journal:  Thorax       Date:  2000-07       Impact factor: 9.139

4.  How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer.

Authors:  J M Gore; C J Brophy; M A Greenstone
Journal:  Thorax       Date:  2000-12       Impact factor: 9.139

5.  Secular trends in nosocomial infections and mortality associated with noninvasive ventilation in patients with exacerbation of COPD and pulmonary edema.

Authors:  Emmanuelle Girou; Christian Brun-Buisson; Solenne Taillé; François Lemaire; Laurent Brochard
Journal:  JAMA       Date:  2003-12-10       Impact factor: 56.272

6.  Noninvasive vs. conventional mechanical ventilation in patients with chronic obstructive pulmonary disease after failure of medical treatment in the ward: a randomized trial.

Authors:  G Conti; M Antonelli; P Navalesi; M Rocco; M Bufi; G Spadetta; G U Meduri
Journal:  Intensive Care Med       Date:  2002-08-30       Impact factor: 17.440

Review 7.  Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis.

Authors:  Josephine V Lightowler; Jadwiga A Wedzicha; Mark W Elliott; Felix S F Ram
Journal:  BMJ       Date:  2003-01-25

8.  Obesity-associated hypoventilation in hospitalized patients: prevalence, effects, and outcome.

Authors:  Sogol Nowbar; Kristin M Burkart; Ralph Gonzales; Andrew Fedorowicz; Wendolyn S Gozansky; Jon C Gaudio; Matthew R G Taylor; Clifford W Zwillich
Journal:  Am J Med       Date:  2004-01-01       Impact factor: 4.965

9.  Changing patterns in long-term noninvasive ventilation: a 7-year prospective study in the Geneva Lake area.

Authors:  Jean-Paul Janssens; Sophie Derivaz; Eric Breitenstein; Benoît De Muralt; Jean-William Fitting; Jean-Claude Chevrolet; Thierry Rochat
Journal:  Chest       Date:  2003-01       Impact factor: 9.410

10.  Epidemiology, treatment and outcome of acidotic, acute, cardiogenic pulmonary oedema presenting to an emergency department.

Authors:  Steven D Crane
Journal:  Eur J Emerg Med       Date:  2002-12       Impact factor: 2.799

View more
  2 in total

1.  Time-dependent accumulation of inorganic mercury in subcellular fractions of kidney, liver, and brain of rats exposed to methylmercury.

Authors:  S Omata; M Sato; K Sakimura; H Sugano
Journal:  Arch Toxicol       Date:  1980-04       Impact factor: 5.153

Review 2.  The influence of nutrition on methyl mercury intoxication.

Authors:  L Chapman; H M Chan
Journal:  Environ Health Perspect       Date:  2000-03       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.